| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8213417c606521630ddcd2a218beeb7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-1864 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
| filingDate |
2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95d79e7927e9f2591377f776bddc01d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ee78fea7a9eb9112cc5276e15fe17e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a064db27bfdf75b7eec8c9e1a70061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d2eae82a77a59f5fb664e08d838de98 |
| publicationDate |
2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019113483-A1 |
| titleOfInvention |
Purification of glucagon-like peptide 1 analogs |
| abstract |
The present invention refers to a method of purifying a glucagon-like peptide 1 analogs, the method comprising a two dimensional reversed phase high performance liquid chromatography protocol, wherein the first step is carried out at a pH value between 7.0 to 7.8 using a mobile phase comprising a phosphate buffer and acetonitrile, and the second step is carried out at a pH value below 3.0 using a mobile phase comprising trifluoroacetic acid and acetonitrile. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112578044-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113624898-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111650313-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110658289-A |
| priorityDate |
2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |